Boston Scientific Corp (BSX)

Payables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cost of revenue (ttm)	US$ in thousands	10,537,000	10,166,000	10,041,000	9,743,000	9,483,000	9,638,000	9,486,000	9,383,000	9,269,000	9,073,000	9,056,000	8,581,000	8,671,000	8,509,000	8,210,000	8,321,000	7,964,000	7,653,000	7,378,000	7,264,000
Payables	US$ in thousands	942,000	929,000	899,000	868,000	862,000	803,000	732,000	696,000	794,000	674,000	689,000	615,000	513,000	452,000	408,000	605,000	542,000	512,000	524,000	498,000
Payables turnover		11.19	10.94	11.17	11.22	11.00	12.00	12.96	13.48	11.67	13.46	13.14	13.95	16.90	18.83	20.12	13.75	14.69	14.95	14.08	14.59

December 31, 2023 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $10,537,000K ÷ $942,000K
= 11.19

The payables turnover ratio for Boston Scientific Corp. has been relatively stable over the past eight quarters, ranging from 4.53 to 5.42. Generally, a higher payables turnover ratio indicates that the company is paying its suppliers more quickly.

In this case, the average payables turnover for the most recent four quarters is 4.59. This suggests that, on average, Boston Scientific Corp. pays off its accounts payable approximately 4.59 times per year. A consistent payables turnover ratio can indicate efficient management of accounts payable and strong supplier relationships.

It is important for investors and stakeholders to monitor the payables turnover ratio over time to ensure that the company's payment practices are sustainable and in line with industry standards. Additionally, changes in the payables turnover ratio could be an indication of shifts in the company's financial health, liquidity, or operational efficiency.